Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Physicians Formula Holdings Inc.

Division of Markwins International Corp.
www.physiciansformula.com

Latest From Physicians Formula Holdings Inc.

Swanson Health Sale Could Lead Private Equity Spike In Supplement Space

Swander Pace Capital's Swanson Health deal announced Jan. 25 is the firm's second in two months in the supplement industry after acquiring Captek Softgel in December. OTC drug and supplement firms in 2016 could be among the consumer product spaces targeted in likely higher private equity investing.

Dietary Supplements

Biopharma Dealmaking Quarterly Statistics, Q3 2012

Q3 2012 biopharma financing, at just over $3 billion, showed a 13% increase over Q2. Follow-on public offerings again were the most prevalent financing type, accounting for a third of these dollars. M&A volume was down to just over $7 billion, compared with Q2’s $35.9 billion and only two Q3 transactions topped the billion-dollar mark. Antibody alliances made up just over a quarter of the total $2.2 billion in deal volume, with 19 deals signed in the area.

BioPharmaceutical Deals

Deals Shaping The Medical Industry, October 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Physicians Formula Goes To Wet N Wild Owner Markwins For $75 Mil.

Markwins International has acquired Physicians Formula Holdings, offering roughly $10 million more than previous suitor Swander Pace Capital. The merger “will strengthen the combined portfolio of brands,” Physicians Formula CEO Ingrid Jackel says.

Consumer United States
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Physicians Formula Cosmetics
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Markwins International Corp.
  • Senior Management
  • Ingrid Jackel, CEO
  • Contact Info
  • Physicians Formula Holdings Inc.
    Phone: (626) 334-3395
    1055 West 8th St.
    Azusa, CA 91702
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register